Development of a method for estimating wall thinning tendency due to flow-accelerated corrosion in tee joint piping by Shun WATANABE, Ryo MORITA

Get full text

Efficacy and Safety of Single-Session Endoscopic Stone Removal for Acute Cholangitis Associated with Choledocholithiasis by Junya Sato, Kazunari Nakahara, Ryo Morita, Nozomi Morita, Keigo Suetani, Yosuke Michikawa, Shinjiro Kobayashi, Fumio Itoh

Get full text

Real‐world first‐line treatment with pembrolizumab for non‐small cell lung carcinoma with high PD‐L1 expression: Updated analysis by Yasuyuki Ikezawa, Ryo Morita, Hidenori Mizugaki, Kazunari Tateishi, Keiki Yokoo, Toshiyuki Sumi, Hajime Kikuchi, Yasuo Kitamura, Atsushi Nakamura, Maki Kobayashi, Mari Aso, Nozomu Kimura, Fumiaki Yoshiike, Furuta Megumi, Hisashi Tanaka, Motoki Sekikawa, Tsutomu Hachiya, Keiichi Nakamura, Fumihiro Hommura, Noriaki Sukoh, Kenichiro Ito, Takashi Kikuchi, Toshihiko Agatsuma, Hiroshi Yokouchi

Get full text

Patient-specific vascular models for optimal catheter selection: Two aneurysm embolization cases by Ryo Morita, MD, PhD, Daisuke Abo, MD, PhD, Takaaki Fujii, MD, Naoya Kinota, MD, Daisuke Kato, MD, Kouji Yamasaki, MD, Motoma Kanaya, MD, Taisuke Harada, MD, PhD, Osamu Sugita, Ph.D, Norio Kawamura, MD, PhD, Akinobu Taketomi, MD, PhD, Kohsuke Kudo, MD, PhD

Get full text

Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902 by Yoko Tsukita, MD, PhD, Rei Umezawa, MD, PhD, Taku Nakagawa, MD, PhD, Akira Anbai, MD, PhD, Tomonori Makiguchi, MD, PhD, Hisashi Tanaka, MD, PhD, Yosuke Horii, MD, PhD, Aya Suzuki, MD, Ryo Morita, MD, PhD, Hitomi Nogawa, MD, Hiroshi Yokouchi, MD, PhD, Nozomu Kimura, MD, PhD, Keiichi Jingu, MD, PhD, Akira Inoue, MD, PhD, Hisatoshi Sugiura, MD, PhD, Eisaku Miyauchi, MD, PhD

Get full text